Parkinson's Disease and Movement Disorders Unit, Neurology Service-Hospital Clínic, Institut de Neurociències and Department of Medicine, Universitat de Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
J Mol Neurosci. 2012 Sep;48(1):245-7. doi: 10.1007/s12031-012-9820-7. Epub 2012 Jun 6.
Mutations in the leucine-rich repeat kinase 2 (LRRK2) and α-synuclein (SNCA) genes are known genetic causes of Parkinson's disease (PD). Recently, a genetic variant in SNCA has been associated with a lower age at onset in idiopathic PD (IPD). We genotyped the SNCA polymorphism rs356219 in 84 LRRK2-associated PD patients carrying the G2019S mutation. We found that a SNCA genetic variant is associated with an earlier age at onset in LRRK2-associated PD. Our results support the notion that SNCA variants can modify the pathogenic effect of LRRK2 mutations as described previously for IPD.
LRRK2 基因和 α-突触核蛋白(SNCA)基因突变是帕金森病(PD)的已知遗传原因。最近,SNCA 基因中的遗传变异与特发性 PD(IPD)的发病年龄较低有关。我们对携带 G2019S 突变的 84 例 LRRK2 相关 PD 患者进行了 SNCA 多态性 rs356219 的基因分型。我们发现,SNCA 遗传变异与 LRRK2 相关 PD 的发病年龄较早有关。我们的结果支持这样一种观点,即正如先前描述的那样,SNCA 变异可以修饰 LRRK2 突变的致病作用。